<DOC>
	<DOC>NCT00163449</DOC>
	<brief_summary>The aim of the present study is to compare the efficacy of inhaled ciclesonide in pre-school children. Ciclesonide will be inhaled once daily, using one of three dose levels and tested versus placebo. The study duration consists of a baseline period (2 to 4 weeks) and a treatment period (24 weeks). The study will provide further data on safety and tolerability of ciclesonide.</brief_summary>
	<brief_title>Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Written informed consent by the parents or legal guardians of the patient Outpatients Good health with the exception of asthma Documented diagnosis of asthma for more than 6 months Use of rescue medication only or pretreatment with a controller drug Main Concomitant severe diseases Diseases contraindicated for the use of inhaled steroids Other relevant lung diseases causing impairment in pulmonary function Recurrent, episodic wheezing only History of lifethreatening asthma History of any mechanical ventilation Clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation Premature birth (&lt; 32 weeks gestation)</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Child</keyword>
	<keyword>Pediatric</keyword>
</DOC>